Stock market week-in-review for 5 large GI companies — Aug. 7-11

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 7 to Aug. 11, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $242.55 on Aug. 7
Peaked: $245.23 on Aug. 8
Closed: $232.88 on Aug. 11
Percent change between Aug 7 to Aug. 11: -3.98 percent

2. Exact Sciences Corp.

Opened: $38.69 on Aug. 7
Peaked: $39.75 on Aug. 7
Closed: $37.76 on Aug. 11
Percent change between Aug 7 to Aug. 11: -2.40 percent

3. Johnson & Johnson

Opened: $133.11 on Aug. 7
Peaked: $134.41 on Aug. 11
Closed: $133.27 on Aug. 11
Percent change between Aug 7 to Aug. 11: 0.12 percent

4. Synergy Pharmaceuticals

Opened: $3.73 on Aug. 7
Peaked: $3.86 on Aug. 8
Closed: $2.96 on Aug. 11
Percent change between Aug 7 to Aug. 11: -20.64 percent

5. Valeant Pharmaceuticals

Opened: $15.09 on Aug. 7
Peaked: $16.89 on Aug. 8
Closed: $13.87 on Aug. 11
Percent change between Aug 7 to Aug. 11: -8.08 percent

More articles on gastroenterology: 
GI center to know: GastroIntestinal Health
Stock market week-in-review for 4 large ASC chains — Aug. 7-11
GI leader to know: Dr. Neil Price of GastroIntestinal Health

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.